Structure Therapeutics Inc.
41.23USD
+0.8500 (+2.10%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -119 | -89 | 24 | -74 | -70 | -56 | -47 | -46 |
| Net Income | -106 | -76 | 33 | -66 | -62 | -47 | -36 | -34 |
| EPS (Diluted) | $-0.49 | $-0.35 | $0.20 | $-0.37 | $-0.36 | $-0.27 | $-0.22 | $-0.20 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)